Clinical Trial Update: Role of Ulinastatin in Preventing Severe Sepsis and Consequent Morbidities and Mortality [Phase 4]

View source ↗

Summary

Phase 4 trial exploring the role of ulinastatin in preventing severe sepsis, septic shock, and related morbidity and mortality.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Organ Dysfunction Syndrome
• Sepsis
• Septic Shock

Drugs mentioned

• Ulinastatin (ulinastatin)

Snippet

Sponsor: Jinnah Postgraduate Medical Centre | Conditions: Severe Sepsis, Septic Shock | Phase 4 | Status: UNKNOWN